Cargando…
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
OBJECTIVE: The study was designed to test the efficacy of ATX-MS-1467 in a relevant preclinical model and to assess its safety for the treatment of patients with secondary progressive multiple sclerosis (SPMS). METHODS: ATX-MS-1467 was tested for its ability to suppress experimental autoimmune encep...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360798/ https://www.ncbi.nlm.nih.gov/pubmed/25798453 http://dx.doi.org/10.1212/NXI.0000000000000093 |